Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR-T as a salvage treatment in polyrefractory RA.

Rheumatology (Oxford, England)·2026
Same author

Clinical Images: Bone Buds as Precursors to Ankylosis in Axial Spondyloarthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

A Strong Correlation Between Pleural Fluid and Serum C-Reactive Protein Levels Across a Spectrum of Pleural Effusions.

Journal of clinical medicine research·2026
Same author

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Rheumatology (Oxford, England)·2026
Same author

Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in SSc: a real-world national cohort study.

Rheumatology (Oxford, England)·2025
Same author

Semaphorin3A Rewires CD4<sup>+</sup> T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis.

International journal of molecular sciences·2025

Related Experiment Videos

Levofloxacin-induced delirium.

Gleb Slobodin1, Nizar Elias, Natalia Zaygraikin

  • 1Department of Internal Medicine A, Bnai Zion Medical Center, P.O. Box 6477, 31063, Haifa, Israel.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|February 4, 2009
PubMed
Summary

This case report highlights a rare side effect of levofloxacin, a common antibiotic. Delirium developed in an elderly patient treated for pneumonia, resolving after discontinuing the medication.

Related Experiment Videos

Area of Science:

  • Pharmacology
  • Geriatric Medicine
  • Infectious Diseases

Background:

  • Pneumonia is a common infection requiring antibiotic treatment.
  • Fluoroquinolones, such as levofloxacin, are frequently used for community-acquired pneumonia.
  • Adverse drug reactions can occur, especially in elderly patients.

Observation:

  • An 83-year-old male patient with right lower lobe pneumonia initially unresponsive to amoxicillin/clavulinate and clarithromycin.
  • Significant clinical improvement was noted within 24 hours of initiating levofloxacin therapy.
  • The patient subsequently developed delirium on the third day of hospitalization, despite being afebrile with normal oxygenation.

Findings:

  • Discontinuation of levofloxacin led to complete resolution of the patient's delirium within 48 hours.
  • This case represents the third documented instance of levofloxacin-induced delirium in medical literature.
  • The temporal association suggests a causal link between levofloxacin and the onset of delirium.

Implications:

  • Clinicians should consider delirium as a potential adverse effect of levofloxacin, particularly in the elderly.
  • Early recognition and discontinuation of the antibiotic may be crucial for managing levofloxacin-induced delirium.
  • Further research is warranted to understand the mechanisms and incidence of fluoroquinolone-associated neuropsychiatric events.